Christopher Previti

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Molecular characterization of mismatch repair deficient tumors in young Jordanian patients.

Molecular characterization of mismatch repair deficient tumors in young Jordanian patients.

Journal: Discover oncology
Published: March 03, 2026

Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience.

Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience.

Journal: Genome medicine
Published: February 17, 2026

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Journal: Cancer research
Published: November 19, 2025

Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene.

Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 09, 2025

Comprehensive investigation of DNA damage repair genes in children with cancer identifies SMARCAL1 as novel osteosarcoma predisposition gene.

Comprehensive investigation of DNA damage repair genes in children with cancer identifies SMARCAL1 as novel osteosarcoma predisposition gene.

Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2025

Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM.

Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM.

Journal: Acta neuropathologica
Published: May 29, 2025

Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targets.

Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targets.

Journal: Neuro-oncology advances
Published: February 03, 2025

Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors.

Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors.

Journal: Cancer research
Published: June 16, 2024

Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.

Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.

Journal: Nature medicine
Published: October 24, 2023

Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.

Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.

Journal: Nature medicine
Published: August 04, 2022

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.

Journal: NPJ precision oncology
Published: May 05, 2022

Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.

Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.

Journal: Acta neuropathologica
Published: January 26, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026